Edition:
United States

Atara Biotherapeutics Inc (ATRA.OQ)

ATRA.OQ on NASDAQ Stock Exchange Global Select Market

14.60USD
17 Nov 2017
Change (% chg)

$0.10 (+0.69%)
Prev Close
$14.50
Open
$14.55
Day's High
$15.02
Day's Low
$14.15
Volume
49,838
Avg. Vol
50,891
52-wk High
$23.00
52-wk Low
$11.80

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -1.020
Jun '17 0.00 -0.938
Mar '17 0.00 -0.883
FY 2016 Dec '16 0.00 -0.631
Sep '16 0.00 -0.881
Jun '16 0.00 -0.659
Mar '16 0.00 -0.580
FY 2015 Dec '15 0.00 -0.747
Sep '15 0.00 -0.429
Jun '15 0.00 -0.617
Mar '15 0.00 -0.418
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 5 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 3 0.00 0.00 0.00 0.00
Year Ending Dec-17 5 0.00 0.00 0.00 0.00
Year Ending Dec-18 5 1.30 6.50 0.00 15.05
Earnings (per share)
Quarter Ending Dec-17 5 -1.15 -1.01 -1.29 -0.95
Quarter Ending Mar-18 3 -1.11 -1.05 -1.19 -0.96
Year Ending Dec-17 5 -4.01 -3.90 -4.14 -4.15
Year Ending Dec-18 6 -4.57 -3.66 -5.41 -4.08
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 197.02 34.53
P/E High - Last 5 Yrs. -- 293.55 45.15
P/E Low - Last 5 Yrs. -- 96.34 24.17
Beta -- 0.86 0.89
Price to Sales (TTM) -- 90.86 5.22
Price to Book (MRQ) 2.17 20.00 5.51
Price to Tangible Book (MRQ) 2.17 23.35 6.98
Price to Cash Flow (TTM) -- 101.29 23.49
% Owned Institutions -- 6.31 1.29

Dividends

  Company industry sector
Dividend Yield -- 0.30 1.50
Dividend Yield - 5 Year Avg -- 0.26 2.03
Dividend 5 Year Growth Rate -- 2.10 5.30
Payout Ratio(TTM) -- 112.04 45.45

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 5.34 6.95
Sales (TTM) vs TTM 1 Yr. Ago -- 29.03 5.19
Sales - 5 Yr. Growth Rate -- 33.61 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -15.83 -141.83 4.91
EPS (TTM) vs TTM 1 Yr. Ago -21.10 -- --
EPS - 5 Yr. Growth Rate -- 43.74 11.02
Capital Spending - 5 Yr. Growth Rate -- 41.54 15.09

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.92 2.53
Current Ratio (MRQ) 12.49 5.60 3.53
LT Debt to Equity (MRQ) 0.00 14.40 12.25
Total Debt to Equity (MRQ) 0.00 16.77 18.21
Interest Coverage (TTM) -- -145.68 43.64

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.49 54.77
Gross Margin - 5 Yr. Avg. -- 54.91 52.26
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -214.25 15.69
Operating Margin (TTM) -- -542.82 8.05
Operating Margin - 5 Yr. Avg. -- -229.97 11.32
Pre-Tax Margin (TTM) -- -510.97 8.85
Pre-Tax Margin - 5 Yr. Avg. -- -229.86 11.74
Net Profit Margin (TTM) -- -507.97 5.09
Net Profit Margin - 5 Yr. Avg. -- -232.83 8.01
Effective Tax Rate (TTM) -- 15.56 24.22
Effective Tax Rate - 5 Yr. Avg. -- 19.22 24.08

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,630,773 862,067,509
Net Income/Employee (TTM) -1,066,802 -1,264,069 100,498,038
Receivable Turnover (TTM) -- 33.44 6.11
Inventory Turnover (TTM) -- 2.69 3.51
Asset Turnover (TTM) 0.00 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -39.84 -7.85 11.35
Return on Assets - 5 Yr. Avg. -- -0.11 12.39
Return on Investment (TTM) -42.33 -10.12 14.52
Return on Investment - 5 Yr. Avg. -- 3.11 16.22
Return on Equity (TTM) -43.02 -37.71 16.01
Return on Equity - 5 Yr. Avg. -- 5.83 17.36
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -23.01 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Atara Biotherapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.00 -0.14 58 58
13 Week 9.36 2.86 69 38
26 Week -3.63 -11.00 53 63
52 Week -20.44 -32.52 38 42
YTD 2.82 -10.74 55 43
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 132
Total Shares Held: 32,794,295
3 Mo. Net Change: 824,190
# New Positions: 8
# Closed Positions: 15
# Increased Positions: 51
# Reduced Positions: 44
# Net Buyers: 7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.